GlassScriptPhysician profile
Aryan Modasi
NPI 1316593114
$7,024.03
in general payments reported to CMS, 2019-2025
13 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.86 · 2020: $17.64 · 2021: $71.91 · 2022: $1,808 · 2023: $2,060 · 2024: $2,850 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,499 · Education: $2,000 · Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,498.51 |
| Education | $2,000.00 |
| Food and Beverage | $597.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,672.46 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $994.85 | 2024 | Phasix Mesh |
| Baxter Healthcare | $79.76 | 2022-2024 | Tisseel |
| Stryker Corporation | $57.29 | 2021 | |
| Ethicon US, LLC | $50.27 | 2021-2023 | Echelon Circular |
| Integra Lifesciences Corporation | $45.71 | 2019-2022 | |
| Medtronic, INC. | $25.02 | 2022 | |
| Dilon Technologies, INC. | $21.57 | 2023 | Hemoblast Bellows |
| Abbvie INC. | $19.48 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.64 | 2020 | |
| Aimmune Therapeutics, INC. | $15.89 | 2024 | |
| Innovation Technologies INC | $15.77 | 2024 | Irrisept |
| Alcresta Therapeutics, INC. | $8.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aryan Modasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.